Multiple myeloma (MM) plasma cells (PC) are CD38(+). A ligand for CD38 is t
he adhesion molecule CD31, By flow cytometry and immunocytochemistry we hav
e investigated whether malignant PC co-express CD38 and CD31. All 68 patien
ts studied were CD38(+). 14/14 monoclonal gammopathies of undetermined sign
ificance (MGUS) and 39/39 plasmacytic MM patients co-expressed CD38 and CD3
1 at high density, Only 1/11 plasmablastic MM and 1/4 plasma cell leukaemia
s (PCL) expressed CD31. These data indicated that PC malignancies co-expres
sed high levels of both CD38 and its ligand CD31, with the exception of pla
smablastic MM and PCL.